Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,536,000 | 1,375,000 | 1,777,000 | 1,915,000 | 1,764,000 |
| Cost of Goods | 1,168,000 | 1,174,000 | 1,345,000 | 1,418,000 | 1,278,000 |
| Gross Profit | 368,000 | 201,000 | 432,000 | 497,000 | 486,000 |
| Operating Expenses | 166,000 | 211,000 | 171,000 | 280,000 | 182,000 |
| Operating Income | 202,000 | -10,000 | 261,000 | 217,000 | 304,000 |
| Interest Expense | 42,000 | 41,000 | 41,000 | 40,000 | 41,000 |
| Other Income | 13,000 | -18,000 | 79,000 | 54,000 | 17,000 |
| Pre-tax Income | 173,000 | -69,000 | 299,000 | 231,000 | 280,000 |
| Income Tax | 28,000 | 28,000 | 59,000 | 30,000 | 46,000 |
| Net Income Continuous | 145,000 | -97,000 | 240,000 | 201,000 | 234,000 |
| Net Income | $145,000 | $-97,000 | $240,000 | $201,000 | $234,000 |
| EPS Basic Total Ops | 0.97 | -0.57 | 1.54 | 1.29 | 1.46 |
| EPS Basic Continuous Ops | 0.97 | -0.57 | 1.54 | 1.29 | 1.46 |
| EPS Diluted Total Ops | 0.96 | -0.56 | 1.52 | 1.26 | 1.43 |
| EPS Diluted Continuous Ops | 0.96 | -0.56 | 1.52 | 1.26 | 1.43 |
| EBITDA(a) | $283,000 | $66,000 | $335,000 | $291,000 | $380,000 |